What does PHARMACIE MATHIEU do?

PHARMACIE MATHIEU is a pharmacy in Sivry-Rance. Private Limited, started on 3 July 2006, 1 establishment.

What is the address of PHARMACIE MATHIEU?

The registered office of PHARMACIE MATHIEU is located at Grand Rue 60, 6470 Sivry-Rance.

Is PHARMACIE MATHIEU still active?

Yes. According to the CBE (31 October 2026) PHARMACIE MATHIEU is active, legal situation “Normale toestand”, started on 3 July 2006.

Is PHARMACIE MATHIEU registered on Peppol?

Yes, PHARMACIE MATHIEU is registered on the Peppol network with ID 0208:0882228955.

What is the enterprise number of PHARMACIE MATHIEU?

The enterprise number of PHARMACIE MATHIEU is BE0882228955.

When was PHARMACIE MATHIEU founded?

PHARMACIE MATHIEU was founded on 3 July 2006.

Who are the directors of PHARMACIE MATHIEU?

According to the 2024 annual accounts, the directors of PHARMACIE MATHIEU are: Didier MATHIEU.

Is PHARMACIE MATHIEU a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 July 2006; 5 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did PHARMACIE MATHIEU make in 2024?

PHARMACIE MATHIEU posted a profit after taxes of € 110,016 in financial year 2024.

What is the revenue of PHARMACIE MATHIEU?

In its most recent annual accounts (2024), PHARMACIE MATHIEU reported revenue of € 1,627,391.

How much does an employee at PHARMACIE MATHIEU earn?

The average wage cost per full-time employee at PHARMACIE MATHIEU was € 57,400 in 2024: staff costs of € 86,154 for 1.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE MATHIEU have?

According to the 2024 annual accounts, PHARMACIE MATHIEU has 1.5 full-time equivalents (FTE).

PHARMACIE MATHIEU (Private Limited) - Sivry-Rance

Dossier PHARMACIE MATHIEU, printed on 31 October 2026 from databakkes.be/en/0882228955/pharmacie-mathieu. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

PHARMACIE MATHIEU from Sivry-Rance, company number BE0882228955, closed financial year 2024 with a result of € 110,016 after tax. For that financial year PHARMACIE MATHIEU recorded revenue of € 1.6 million and equity of € 1.1 million. Compared with financial year 2023, the result moved from € 96,683 to € 110,016. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 11, 2025.

What it is worth Growing

€ 1.1 million

▲ 4% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 110,016

▲ 14% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 220,136

▲ 16% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 71,000 paid out

65 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2024

Full-time equivalents

1.5

▼ 0.1 vs 2023

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 86,154

▲ 15% vs 2023

€ 57,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 8,380

▼ 9% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 162,296

▼ 14% vs 2023

€ 32,111 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 146,327

▼ 9% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 38,374

▼ 48% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Revenue	€ 1,450,030 Revenue 2021: € 1,450,030 First fiscal year in the series	€ 1,566,973 Revenue 2022: € 1,566,973 ▲ 8% vs 2021 (€ 1,450,030) Favourable step	€ 1,547,959 Revenue 2023: € 1,547,959 ▼ 1% vs 2022 (€ 1,566,973) Unfavourable step	€ 1,627,391 Revenue 2024: € 1,627,391 ▲ 5% vs 2023 (€ 1,547,959) Favourable step	▲ 5%
Gross margin	€ 267,829 Gross margin 2021: € 267,829 First fiscal year in the series	€ 277,634 Gross margin 2022: € 277,634 ▲ 4% vs 2021 (€ 267,829) Favourable step	€ 262,609 Gross margin 2023: € 262,609 ▼ 5% vs 2022 (€ 277,634) Unfavourable step	€ 294,833 Gross margin 2024: € 294,833 ▲ 12% vs 2023 (€ 262,609) Favourable step	▲ 12%
Profit after taxes	€ 94,136 Profit after taxes 2021: € 94,136 First fiscal year in the series	€ 98,513 Profit after taxes 2022: € 98,513 ▲ 5% vs 2021 (€ 94,136) Favourable step	€ 96,683 Profit after taxes 2023: € 96,683 ▼ 2% vs 2022 (€ 98,513) Unfavourable step	€ 110,016 Profit after taxes 2024: € 110,016 ▲ 14% vs 2023 (€ 96,683) Favourable step	▲ 14%
Equity	€ 889,056 Equity 2021: € 889,056 First fiscal year in the series	€ 916,569 Equity 2022: € 916,569 ▲ 3% vs 2021 (€ 889,056) Favourable step	€ 1,013,253 Equity 2023: € 1,013,253 ▲ 11% vs 2022 (€ 916,569) Favourable step	€ 1,052,268 Equity 2024: € 1,052,268 ▲ 4% vs 2023 (€ 1,013,253) Favourable step	▲ 4%
Total debts	€ 658,946 Total debts 2021: € 658,946 First fiscal year in the series	€ 569,541 Total debts 2022: € 569,541 ▼ 14% vs 2021 (€ 658,946) Favourable step	€ 482,374 Total debts 2023: € 482,374 ▼ 15% vs 2022 (€ 569,541) Favourable step	€ 406,931 Total debts 2024: € 406,931 ▼ 16% vs 2023 (€ 482,374) Favourable step	▼ 16%
Cash	€ 152,265 Cash 2021: € 152,265 First fiscal year in the series	€ 189,399 Cash 2022: € 189,399 ▲ 24% vs 2021 (€ 152,265) Favourable step	€ 190,119 Cash 2023: € 190,119 Unchanged (€ 189,399) Favourable step	€ 220,136 Cash 2024: € 220,136 ▲ 16% vs 2023 (€ 190,119) Favourable step	▲ 16%
Land & buildings	€ 459,050 Land & buildings 2021: € 459,050 First fiscal year in the series	€ 446,676 Land & buildings 2022: € 446,676 ▼ 3% vs 2021 (€ 459,050) Unchanged	€ 422,734 Land & buildings 2023: € 422,734 ▼ 5% vs 2022 (€ 446,676) Unchanged	€ 399,208 Land & buildings 2024: € 399,208 ▼ 6% vs 2023 (€ 422,734) Unchanged	▼ 6%
Retained profit	€ 824,056 Retained profit 2021: € 824,056 First fiscal year in the series	€ 851,569 Retained profit 2022: € 851,569 ▲ 3% vs 2021 (€ 824,056) Favourable step	€ 948,253 Retained profit 2023: € 948,253 ▲ 11% vs 2022 (€ 851,569) Favourable step	€ 987,268 Retained profit 2024: € 987,268 ▲ 4% vs 2023 (€ 948,253) Favourable step	▲ 4%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 71,000 Dividend 2022: € 71,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 71,000) Unchanged	€ 71,000 Dividend 2024: € 71,000 Unchanged (€ 0) Unchanged
Bank debt	€ 366,831 Bank debt 2021: € 366,831 First fiscal year in the series	€ 263,003 Bank debt 2022: € 263,003 ▼ 28% vs 2021 (€ 366,831) Favourable step	€ 188,290 Bank debt 2023: € 188,290 ▼ 28% vs 2022 (€ 263,003) Favourable step	€ 162,296 Bank debt 2024: € 162,296 ▼ 14% vs 2023 (€ 188,290) Favourable step	▼ 14%
Balance sheet total	€ 1,548,002 Balance sheet total 2021: € 1,548,002 First fiscal year in the series	€ 1,486,110 Balance sheet total 2022: € 1,486,110 ▼ 4% vs 2021 (€ 1,548,002) Unchanged	€ 1,495,627 Balance sheet total 2023: € 1,495,627 ▲ 1% vs 2022 (€ 1,486,110) Unchanged	€ 1,459,200 Balance sheet total 2024: € 1,459,200 ▼ 2% vs 2023 (€ 1,495,627) Unchanged	▼ 2%
Employees (FTE)	1.6 Employees (FTE) 2021: 1.6 First fiscal year in the series	1.6 Employees (FTE) 2022: 1.6 Unchanged (1.6) Unchanged	1.6 Employees (FTE) 2023: 1.6 Unchanged (1.6) Unchanged	1.5 Employees (FTE) 2024: 1.5 ▼ 0.1 vs 2023 (1.6) Unchanged	▼ 0.1

Key figures of PHARMACIE MATHIEU, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to PHARMACIE MATHIEU?

What happened at PHARMACIE MATHIEU in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 11, 2025 New annual accounts for financial year 2024: profit of € 110,016 (▲ 14% vs 2023). filed late Source: NBB ↗
2023 Didier MATHIEU became a director. NBB
Jul 3, 2006 New establishment in Sivry-Rance. KBO
Jul 3, 2006 Start of the company according to the CBE. KBO

In short

From € 94,136 profit in 2021 to € 110,016 profit in 2024.

Paid € 186,887 in corporate taxes since 2021.

Best year ever: 2024, with € 110,016 profit.

On average € 196,600 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

Didier MATHIEU

PHARMACIE MATHIEU

Behind PHARMACIE MATHIEU is Didier MATHIEU.

Directors

According to the 2024 annual accounts

Didier MATHIEU

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Grand Rue 60

6470 Sivry-Rance

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0882.228.955

VAT number

BE 0882.228.955

Registered office

Grand Rue 60, 6470 Sivry-Rance

Names & denominations

PHARMACIE MATHIEU

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

3 July 2006

Peppol

Active · Active since 12 Jan 2026

Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE MATHIEU

Financials

What happened to PHARMACIE MATHIEU?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions